Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1

Glucocorticoids such as dexamethasone are widely co-prescribed with cytotoxic therapy because of their proapoptotic effects in lymphoid cancer, reduction of inflammation and edema and additional benefits. Concerns about glucocorticoid-induced therapy resistance, enhanced metastasis and reduced survi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Death Dis
Egile Nagusiak: Liu, Li, Aleksandrowicz, Ewa, Schönsiegel, Frank, Gröner, Daniel, Bauer, Nathalie, Nwaeburu, Clifford C, Zhao, Zhefu, Gladkich, Jury, Hoppe-Tichy, Torsten, Yefenof, Eitan, Hackert, Thilo, Strobel, Oliver, Herr, Ingrid
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2017
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680577/
https://ncbi.nlm.nih.gov/pubmed/28981109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.455
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak